SE8600202L - Farmaceutisk komposition (ii) - Google Patents

Farmaceutisk komposition (ii)

Info

Publication number
SE8600202L
SE8600202L SE8600202A SE8600202A SE8600202L SE 8600202 L SE8600202 L SE 8600202L SE 8600202 A SE8600202 A SE 8600202A SE 8600202 A SE8600202 A SE 8600202A SE 8600202 L SE8600202 L SE 8600202L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
new
compound
relates
present
Prior art date
Application number
SE8600202A
Other languages
English (en)
Other versions
SE8600202D0 (sv
SE462529B (sv
Inventor
C H Appelgren
C Eskilsson
Original Assignee
Lejus Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20354249&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8600202(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lejus Medical Ab filed Critical Lejus Medical Ab
Publication of SE8600202D0 publication Critical patent/SE8600202D0/sv
Publication of SE8600202L publication Critical patent/SE8600202L/sv
Publication of SE462529B publication Critical patent/SE462529B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
SE8600202A 1984-01-10 1986-01-17 Metoprololsuccinat samt farmaceutisk komposition innehaallande detsamma SE462529B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8400085A SE457505B (sv) 1984-01-10 1984-01-10 Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning

Publications (3)

Publication Number Publication Date
SE8600202D0 SE8600202D0 (sv) 1986-01-17
SE8600202L true SE8600202L (sv) 1986-01-17
SE462529B SE462529B (sv) 1990-07-09

Family

ID=20354249

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8400085A SE457505B (sv) 1984-01-10 1984-01-10 Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
SE8600202A SE462529B (sv) 1984-01-10 1986-01-17 Metoprololsuccinat samt farmaceutisk komposition innehaallande detsamma

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8400085A SE457505B (sv) 1984-01-10 1984-01-10 Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning

Country Status (7)

Country Link
US (2) US4780318A (sv)
EP (2) EP0148811B1 (sv)
AT (2) ATE77077T1 (sv)
DE (2) DE3572767D1 (sv)
HK (1) HK24995A (sv)
SE (2) SE457505B (sv)
SG (1) SG2295G (sv)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
JPS57500432A (sv) * 1980-03-20 1982-03-11
JPS6261916A (ja) * 1985-09-12 1987-03-18 Fujisawa Pharmaceut Co Ltd 持続性製剤
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
US4717567A (en) * 1985-11-25 1988-01-05 Eastman Kodak Company Rumen-stable pellets
GB2186485B (en) * 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
AU591248B2 (en) * 1986-03-27 1989-11-30 Kinaform Technology, Inc. Sustained-release pharaceutical preparation
US5238686A (en) * 1986-03-27 1993-08-24 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
EP0294493A4 (en) * 1986-12-25 1989-07-24 Teysan Pharmaceuticals Co Ltd SLOW DISSOLUTION GRANULE AND COMPOSITE GRANULE WITH PERSISTENT EFFECT PREPARED FROM THE FIRST GRANULE.
SE460945B (sv) * 1987-01-15 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av furosemid
US4789549A (en) * 1987-03-09 1988-12-06 Warner-Lambert Company Sustained release dosage forms
SE460946B (sv) * 1987-03-16 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av kinidinglukonat
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
IL88083A (en) * 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
FI101344B (sv) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Förfarande för framställning av ett preparat för kontrollerat frigörin g av ett farmaceutiskt aktivt ämne
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
FR2634376B1 (fr) * 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
EP0352800A3 (en) * 1988-07-28 1991-05-08 Warner-Lambert Company Aqueous polymeric dispersion of cellulosic and acrylic based polymers for preparing pharmaceutical dosage forms and dosage forms thereof
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
GB8913889D0 (en) * 1989-06-16 1989-08-02 May & Baker Ltd New compositions of matter
GB8915137D0 (en) * 1989-06-30 1989-08-23 Inmos Ltd Message routing
US5422881A (en) * 1989-06-30 1995-06-06 Inmos Limited Message encoding
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
EP0458751A1 (en) * 1990-05-25 1991-11-27 Warner-Lambert Company Delivery system for cyclic amino acids with improved taste, texture and compressibility
JPH06502391A (ja) * 1990-07-26 1994-03-17 ジー．ディー．サール　アンド　カンパニー ポリマー性薬剤送達システム
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
SG42869A1 (en) * 1992-08-05 1997-10-17 Faulding F H & Co Ltd Pelletised pharmaceutical composition
US5654004A (en) * 1992-11-06 1997-08-05 Hisamitsu Pharmaceutical Co., Inc. Oral pharmaceutical preparation releasable in the lower digestive tract
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
EP0621032B1 (en) * 1993-04-23 2000-08-09 Novartis AG Controlled release drug delivery device
DE4329503A1 (de) * 1993-09-01 1995-03-02 Galenik Labor Freiburg Gmbh Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa
US6204243B1 (en) 1993-09-01 2001-03-20 Novatis Ag Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
US6039975A (en) * 1995-10-17 2000-03-21 Hoffman-La Roche Inc. Colon targeted delivery system
CN1155369C (zh) * 1995-12-21 2004-06-30 药物实验室费林公司 含有5-asa的控释口服药物组合物及其治疗肠道疾病的方法
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
DE19845358A1 (de) 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
US6962717B1 (en) 1999-01-29 2005-11-08 Disphar International B.V. Pharmaceutical compositions
ATE448194T1 (de) 2000-08-29 2009-11-15 Biocon Ltd Verwendung einer pharmazeutischen zusammensetzung mit einem para-aminophenylessigsäurederivat für die behandlung von entzündlichen erkrankungen des magen-darmtrakts
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US6610326B2 (en) 2001-02-16 2003-08-26 Andrx Corporation Divalproex sodium tablets
US20040105886A1 (en) * 2001-02-16 2004-06-03 Chih-Ming Chen Divalproex sodium tablets
ES2436523T3 (es) * 2001-03-13 2014-01-02 Endo Pharmaceuticals Inc. Formas de dosificación terapéutica
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US6500454B1 (en) * 2001-10-04 2002-12-31 Eurand Pharmaceuticals Ltd. Timed, sustained release systems for propranolol
US9358214B2 (en) * 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
AR036797A1 (es) 2001-10-15 2004-10-06 Ferring Bv Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
WO2003057196A1 (en) * 2002-01-07 2003-07-17 Pharmacia Corporation Drug mixture with enhanced dissolution rate
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
AU2003230805A1 (en) * 2002-04-05 2003-10-27 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
AU2003282375A1 (en) * 2003-02-05 2004-08-30 Ipca Laboratories Limited Pharmaceutical compositions and process of production thereof
JP2007523664A (ja) 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050032879A1 (en) * 2003-08-07 2005-02-10 Temple Okarter Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases
EP1670442A4 (en) * 2003-09-19 2011-09-14 Penwest Pharmaceuticals Co DOSAGE FORMS WITH DELAYED RELEASE
JP2007519608A (ja) * 2003-09-19 2007-07-19 ペンウェスト ファーマシューティカルズ カンパニー 時間治療用剤形
EP1547601A1 (en) 2003-12-23 2005-06-29 Ferring B.V. Coating method
MXPA06009054A (es) * 2004-02-11 2007-04-16 Athpharma Ltd Composiciones cronoterapeuticas y metodos de su uso.
US7932366B2 (en) 2004-07-07 2011-04-26 Biocon Limited Synthesis of azo bonded immunoregulatory compounds
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP1802285B1 (en) 2004-10-21 2013-02-27 Aptalis Pharmatech, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
WO2006070930A1 (en) 2004-12-27 2006-07-06 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US20070087056A1 (en) * 2005-08-09 2007-04-19 Claudia Guthmann Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
US20070053983A1 (en) * 2005-09-06 2007-03-08 Girish Jain Extended release compositions of metoprolol succinate
EP1971570A2 (en) * 2005-12-23 2008-09-24 Medichem, S.A. Process for the preparation of metoprolol and its salts
US20090028944A1 (en) * 2007-07-16 2009-01-29 Balaji Sathurappan Pharmaceutical compositions comprising mesalamine
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
US20090062191A1 (en) * 2007-08-29 2009-03-05 Kiel Laboratories, Inc. Composition for maintaining gastrointestinal homeostasis
US20090214665A1 (en) * 2008-02-26 2009-08-27 Lai Felix S Controlled Release Muscarinic Receptor Antagonist Formulation
JP5740306B2 (ja) 2008-10-03 2015-06-24 ドクトル ファルク ファルマ ゲーエムベーハー メサラミン顆粒を用いて腸疾患を治療するための組成物および方法
ATE533475T1 (de) 2009-04-03 2011-12-15 Zaklady Farmaceutyczne Polpharma Sa Pharmazeutische zusammensetzung mit verlängerter freisetzung mit metoprololsuccinat
CN102008457B (zh) * 2009-09-04 2014-04-02 北京天衡药物研究院 酒石酸美托洛尔骨架缓释片
AU2010325746B2 (en) 2009-12-02 2016-02-25 Adare Pharmaceuticals S.R.L. Fexofenadine microcapsules and compositions containing them
IL210279A0 (en) 2009-12-25 2011-03-31 Dexcel Pharma Technologies Ltd Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2099402A (en) * 1934-01-17 1937-11-16 Pratt Food Company Pill or tablet
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
DE1204363B (de) * 1963-09-10 1965-11-04 Hoffmann La Roche Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt
NL130749C (sv) * 1964-09-10
US3483221A (en) * 1964-09-10 1969-12-09 Ciba Geigy Corp 1 - (isopropylamino)-2-hydroxy-3-(alkenyloxyphenoxy) - propanes and the salts thereof
AT270071B (de) * 1966-08-12 1969-04-10 Roehm & Haas Gmbh Dragierlack für Arzneiformen
US3629237A (en) * 1968-09-12 1971-12-21 Shinetsu Chemical Co Compositions useful as enteric coatings and method for preparing acid phthalates of cellulose ethers for them
SE384853B (sv) * 1972-04-04 1976-05-24 Haessle Ab Forfarande for framstellning av nya aminer
SE354851B (sv) * 1970-02-18 1973-03-26 Haessle Ab
US3909444A (en) * 1971-08-05 1975-09-30 Ncr Co Microcapsule
US4145442A (en) * 1972-04-04 1979-03-20 Aktiebolaget Hassle Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases
IL43853A0 (en) * 1973-02-16 1974-03-14 Sparamedica Ag Pharmaceutical compositions and their manufacture
JPS5518694B2 (sv) * 1973-04-02 1980-05-21
GB1413186A (en) * 1973-06-27 1975-11-12 Toyo Jozo Kk Process for encapsulation of medicaments
SE385693B (sv) * 1973-10-08 1976-07-19 Haessle Ab Forfarande for framstellning av nya aminer
SE388849B (sv) * 1974-02-14 1976-10-18 Haessle Ab Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan
JPS5512411B2 (sv) * 1974-03-12 1980-04-02
ZA754241B (en) * 1974-11-01 1976-06-30 Haessle Ab New amines
SE402765B (sv) * 1975-06-04 1978-07-17 Haessle Ab Forfarande for framstellning av en ny hjertaktiv forening
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
DE2645710C2 (de) * 1976-10-09 1985-06-27 Merck Patent Gmbh, 6100 Darmstadt Phenoxy-amino-propanole, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung
US4218433A (en) * 1977-03-03 1980-08-19 Nippon Kayaku Kabushiki Kaisha Constant-rate eluting tablet and method of producing same
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
DE2905134A1 (de) * 1978-02-17 1979-08-23 Degussa Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest
SE426548B (sv) * 1978-12-05 1983-01-31 Haessle Ab Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer
GB2051574B (en) * 1979-05-10 1984-01-18 Kyoto Pharma Ind Adjuvant for promoting absorption of pharmacologically active substances through the rectum
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
EP0064485B1 (en) * 1981-04-27 1985-07-24 Aktiebolaget Hässle New pharmaceutical preparation
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3208791A1 (de) * 1982-03-11 1983-09-22 Röhm GmbH, 6100 Darmstadt Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels
EP0094117A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
JPS5920219A (ja) * 1982-07-26 1984-02-01 Shin Etsu Chem Co Ltd 腸溶性コ−テイング製剤の製造方法
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4627850A (en) * 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
AU565354B2 (en) * 1983-11-14 1987-09-10 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
US4623588A (en) * 1984-02-06 1986-11-18 Biotek, Inc. Controlled release composite core coated microparticles
DE3405378A1 (de) * 1984-02-15 1985-08-22 Röhm GmbH, 6100 Darmstadt Arzneimittelueberzug

Also Published As

Publication number Publication date
DE3586206D1 (de) 1992-07-16
SE8600202D0 (sv) 1986-01-17
EP0148811A1 (en) 1985-07-17
SE8400085L (sv) 1985-07-11
SE457505B (sv) 1989-01-09
DE3586206T2 (de) 1992-12-24
SG2295G (en) 1995-06-16
SE462529B (sv) 1990-07-09
US4780318A (en) 1988-10-25
SE8400085D0 (sv) 1984-01-10
US5001161A (en) 1991-03-19
EP0293347B1 (en) 1992-06-10
ATE77077T1 (de) 1992-06-15
ATE46080T1 (de) 1989-09-15
DE3572767D1 (en) 1989-10-12
EP0148811B1 (en) 1989-09-06
HK24995A (en) 1995-03-03
EP0293347A1 (en) 1988-11-30

Similar Documents

Publication Publication Date Title
SE8600202L (sv) Farmaceutisk komposition (ii)
DE3587577T2 (de) Antimykotische pharmazeutische Präparate.
FI862094A (fi) Bornerande terapeutisk komposition.
FI844562L (fi) Maetanordning foer metaboliska storheter anslutbar till en respirator.
DE3586545D1 (de) Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen.
DE3677276D1 (de) Photopolymerisierbare zusammensetzung.
DE3586503T2 (de) Photohaertbare zusammensetzung.
DE3580304D1 (de) Arzneimittel.
DE3674593D1 (de) Medizinische zusammensetzung.
DE3587705T2 (de) Kombinierte Düngemittelzusammensetzung.
DE3669105D1 (de) Therapeutische zusammensetzung.
NO862439L (no) Farmasoeytiske preparater.
IT1213453B (it) Composizione farmaceutica.
DE3586765D1 (de) Immunogenische hav-peptide.
DE3579911D1 (de) Stabiles grf-praeparat.
NO873886D0 (no) Topiske antiinflammatoriske preparater.
IT8521235A0 (it) Composti farmacologicamente attivi.
DE3577108D1 (de) Modifizierte urokinase-zusammensetzung.
IT8783379A0 (it) Composizioni farmaceutiche antimicotiche.
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
ATE50495T1 (de) Pharmazeutische praeparate.
IT8422446A0 (it) Composti farmacologicamente attivi.
ATE50498T1 (de) Therapeutische zusammensetzung.
IT8421406A0 (it) Composto chimico ad attivita' antimicotica, cicatrizzante, antiinfiammatoria.
SU1264554A1 (ru) 2-Окси-3,5-дибромбензилиденгидразид дибутилгликолевой кислоты, обладающий анальгетической и противовоспалительной активностью

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8600202-9

Format of ref document f/p: F

NUG Patent has lapsed